Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner

Journal of Alzheimer's Disease

Volumn 58, Issue 1, 2017, Pages 193-201

  Gardener, Samantha L ^a,b   Rainey Smith, Stephanie R ^a,b   Sohrabi, Hamid R ^a,b,c   Weinborn, Michael ^a,b,d   Verdile, Giuseppe ^a,b,e   Fernando, W M A D Binosha ^a,b   Lim, Yen Ying ^f   Harrington, Karra ^f,g   Burnham, Samantha ^h   Taddei, Kevin ^a,b   Masters, Colin L ^f   Macaulay, Stuart L ^h   Rowe, Christopher C ⁱ   Ames, David ^f,j   Maruff, Paul ^k   Martins, Ralph N ^a,b,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e CURTIN UNIVERSITY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g University of Melbourne   (Australia)

^h CSIRO   (Australia)

ⁱ AUSTIN HEALTH   (Australia)

^j ROYAL MELBOURNE HOSPITAL   (Australia)

^k Scientific Division   (Australia)

more..

Author keywords

Amyloid load; apolipoprotein E; attention; carbohydrates; cognition; PiB PET; verbal memory

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CARBOHYDRATE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CARBOHYDRATE INTAKE; COGNITION; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PRIORITY JOURNAL; RISK; VERBAL MEMORY; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; GENETICS; IMAGE PROCESSING; MEMORY DISORDER; METABOLISM; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; VERBAL LEARNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; ATTENTION; CARBOHYDRATES; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; VERBAL LEARNING;

EID: 85019101072     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-161158     Document Type: Article

References (44)

1. Klein P, Tyrlikova I, Mathews GC (2014) Dietary treatment in adults with refractory epilepsy: A review. Neurology 83, 1978-1985.
2. Paoli A, Rubini A, Volek JS, Grimaldi KA (2013) Beyond weight loss: A review of the therapeutic uses of very-lowcarbohydrate (ketogenic) diets. Eur J Clin Nutr 67, 789-796.
3. Woolf EC, Scheck AC (2015) The ketogenic diet for the treatment of malignant glioma. J Lipid Res 56, 5-10.
4. Kashiwaya Y, Bergman C, Lee JH, Wan R, King MT, Mughal MR, Okun E, Clarke K, Mattson MP, Veech RL (2013)Aketone ester diet exhibits anxiolytic and cognitionsparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging 34, 1530-1539.
5. Van der Auwera I, Wera S, Van Leuven F, Henderson ST (2005) A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond) 2, 28.
6. Krikorian R, ShidlerMD,Dangelo K, Couch SC, Benoit SC, Clegg DJ (2012) Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging 33, 425 e419-427.
7. Beckett TL, Studzinski CM, Keller JN, Paul Murphy M, Niedowicz DM (2013) A ketogenic diet improves motor performance but does not affect beta-amyloid levels in a mouse model of Alzheimer's disease. Brain Res 1505, 61-67.
8. Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S (2004) Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25, 311-314.
9. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC (2009) Study of the ketogenic agentAC-1202 in mild to moderate Alzheimer's disease: A randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 6, 31.
10. Ittner LM, Gotz J (2011) Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12, 65-72.
11. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68, 1718-1725.
12. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL, Australian Imaging B, Lifestyle Research G (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurol 12, 357-367.
13. Karch CM, Goate AM (2015) Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77, 43-51.
14. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31, 1275-1283.
15. Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, Ames D, Keogh JB, Scarmeas N, Martins RN (2015) Dietary patterns and cognitive decline in an Australian study of ageing. Mol Psychiatry 20, 860-866.
16. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K,VillemagneV,Woodward M, AmesD(2009) The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21, 672-687.
17. Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G(2000) The Anti Cancer Council of Victoria FFQ: Relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 24, 576-583.
18. Pike KE, Ellis KA, Villemagne VL, Good N, Chetelat G, Ames D, Szoeke C, Laws SM, Verdile G, Martins RN, Masters CL, Rowe CC (2011) Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study. Neuropsychologia 49, 2384-2390.
19. Harrington KD, Lim YY, Ellis KA, Copolov C, Darby D, Weinborn M, Ames D, Martins RN, Savage G, Szoeke C, Rowe C, Villemagne VL, Masters CL, Maruff P (2013) The association of Abeta amyloid and composite cognitive measures in healthy older adults and MCI. Int Psychogeriatr 25, 1667-1677.
20. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548.
21. Pike KE, Savage G,Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC (2007) Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease. Brain 130, 2837-2844.
22. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G,Wang R, Hof PR, Pasinetti GM (2005) Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 19, 659-661.
23. Bordone L, Guarente L (2005) Calorie restriction, SIRT1 and metabolism: Understanding longevity. Nat Rev Mol Cell Biol 6, 298-305.
24. Kanoski SE, Davidson TL (2011)Western diet consumption and cognitive impairment: Links to hippocampal dysfunction and obesity. Physiol Behav 103, 59-68.
25. Martyn JA, Kaneki M, Yasuhara S (2008) Obesity-induced insulin resistance and hyperglycemia: Etiologic factors and molecular mechanisms. Anesthesiology 109, 137-148.
26. Verdile G, Fuller SJ, Martins RN (2015) The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 84, 22-38.
27. Reger MA,Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH, 2nd, Craft S (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 13, 323-331.
28. Park CR, Seeley RJ, Craft S, Woods SC (2000) Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 68, 509-514.
29. Gross LS, Li L, Ford ES, Liu S (2004) Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: An ecologic assessment. Am J Clin Nutr 79, 774-779.
30. Woods SC, Seeley RJ, Baskin DG, Schwartz MW (2003) Insulin and the blood-brain barrier. Curr Pharm Des 9, 795-800.
31. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS,Wortman JA,Yancy WS, Phinney SD(2007) Lowcarbohydrate nutrition and metabolism. Am J Clin Nutr 86, 276-284.
32. Adam-Perrot A, Clifton P, Brouns F (2006) Lowcarbohydrate diets: Nutritional and physiological aspects. Obes Rev 7, 49-58.
33. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, KukullW, Morris JC, Hulette CM, Schmechel D, Rogers J, Stephan DA (2008) Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 105, 4441-4446.
34. Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP (2000) Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 48, 297-303.
35. Robinson AM, Williamson DH (1980) Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 60, 143-187.
36. Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochem J 343 Pt 2, 281-299.
37. Ireland P, JolleyD, Giles G, O'Dea K, Powles J, Rutishauser I, Wahlqvist ML, Williams J (1994) Development of the Melbourne FFQ: A food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 3, 19-31.
38. WechslerD(1945)Astandardised memory scale for clinical use. Journal of Psychology 19, 87-95.
39. Delis DC, Kramer JH, Keplan E, Ober B (2000) California Verbal Learning Test-Second Edition, Psychological Corporation, San Antonio, TX.
40. Meyers JE, Meyers KR (1995) Rey Complex Figure Test and Recognition Trial. Professional Manual, Psychological Assessment Resource, Inc.
41. Strauss E, Sherman, Spreen O (2006) A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd edn), Oxford University Press, NewYork.
42. Delis DC, Kaplan E, Kramer JH (2001) Delis-Kaplan Executive Funtion System (D-KEFS), Psychological Corporation, San Antonio, TX.
43. Saxton J, Ratcliff G, Munro CA, Coffey EC, Becker JT, Fried L, Kuller L (2000) Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clin Neuropsychol 14, 526-534.
44. Wechsler D (1997) Wechsler Adult Intelligence Scale, 3rd edition (WAIS-III), Psychological Corporation, San Antonio, TX.